DIRS.INFO The most relevant business & tech news

☆ Cramer's Lightning Round: Don't sell Match Group
▼ + stars: | 2024-07-16 | by ( Julie Coleman | ) www.cnbc.com time to read: +2 min

Stock Chart Icon Stock chart icon Fortinet's year-to-date stock performance. Stock Chart Icon Stock chart icon Sarepta Therapeutics' year-to-date stock performance. Stock Chart Icon Stock chart icon Toast's year-to-date stock performance. Stock Chart Icon Stock chart icon Teva Pharmaceutical's year-to-date stock performance. Stock Chart Icon Stock chart icon Viking Holdings' year-to-date stock performance.

Persons: Palo, Linde's, you've, You've, there's, Teva, Eli Lilly, Jim Cramer's Organizations: Charitable Trust, Products, Air Products, Therapeutics, Sarepta Therapeutics, BJ's Wholesale, Costco, ., Teva, Viking Holdings, Royal Locations: Palo Alto, Linde, Royal Caribbean

☆ CNBC Pro Talks: From weight loss drugs to AI winners, CIO set to reveal his top stocks
▼ + stars: | 2024-07-16 | by ( ) www.cnbc.com time to read: +2 min

Weight loss drugs and artificial intelligence have been dominating headlines, with investors betting that stocks in both categories have big potential upside. On Wednesday's Pro Talks , CNBC's Senior Technology Correspondent Arjun Kharpal will ask Tema ETFs' Yuri Khodjamirian how to best invest in these areas and more. Tema ETFs offers actively managed ETFs, with a focus on healthcare and life sciences. Before Tema ETFs, Khodjamirian spent over a decade at Majedie Asset Management, overseeing U.K. and global portfolios. Click here to join CNBC Pro Talks on Wednesday, July 17, at 7 a.m.

Persons: Arjun Kharpal, Yuri Khodjamirian, Eli Lilly, he'll, Khodjamirian Organizations: Tema, Novo Nordisk, pharma, Majedie Asset Management, Income, CNBC, Nvidia, Scotiabank Locations: Tema, —, U.S, U.K, India

☆ Team USA has owned the Olympic swimming pool — is that about to change in Paris?
▼ + stars: | 2024-07-16 | by ( Nicole Auerbach | ) www.nytimes.com time to read: +9 min

Its anthem played, over and over again, as the Americans received their gold medals atop the podium. AdvertisementU.S. swimmers have won the overall medal count and the gold medal count so often over the years that it almost has been taken for granted. Heading into the Paris Games, the Australians will be favored to win the most gold medals in the pool. Of the nine swimmers who won multiple individual gold medals, Katie Ledecky was the only American swimmer to do so. Still, USA Swimming president and CEO Tim Hinchey III has said the organization’s goal is to win the total medal count and the gold medal count.

Persons: Michael Phelps, wasn’t, Todd DeSorbo, we’ve, —, ”, Cate Campbell, ” Campbell, Katie Ledecky, Bob Bowman, Caeleb Dressel, Simone Manuel, Sarah Stier, Campbell, Phelps, he’d, we’ll, ” Phelps, Mollie O’Callaghan, Dressel, he’s, Bobby Finke, Ryan Murphy, Gretchen Walsh, Regan Smith, Kate Douglass, Walsh, Smith, Kaylee McKeown, Maggie Mac Neil, Summer McIntosh, Zhang Yufei, Douglass, McIntosh, McKeown, Alex Walsh, breaststroker Lilly King, Katie Grimes, breaststrokers Nic Fink, Matt Fallon, Carson Foster, Frenchman, Léon Marchand, Ryan Lochte, Ledecky, Lochte, Tim Hinchey, ” DeSorbo, “ We’re, Dan Goldfarb, Tom Pennington, Al Bello Organizations: Paris Games, Team USA, ” Count, “, Australia’s, NBC, Ledecky, Games Locations: Barcelona, Tokyo, United States, East Germany, Fukuoka, Japan, Paris, U.S, “ Australia, China, Britain, Rio de Janeiro, Ledecky, USA, Croatia

☆ Shares of this controversial health-care stock poised to break out to new high, according to the charts
▼ + stars: | 2024-07-16 | by ( Todd Gordon | ) www.cnbc.com time to read: +3 min

Shares of Hims & Hers (HIMS) , a digital consumer-facing health-care company, look poised to break out to a new all time high, according to the charts. HIMS announced in May a controversial weight loss injection product to compete with Lilly's Ozempic and Novo Nordisk's Wegovy. HIMS is not only marketing weight loss drugs, it has over one million subscribers using a wide variety of treatments. It's no secret that the total addressable market for weight loss drugs is gigantic. he volume was massive that day at over 70 million shares traded with average daily volume at round 18 million.

Persons: Howard Marks, HIMS, Lilly's, We've, Goldman Sachs, Eli Lilly's, Todd Gordon, Gordon Organizations: Capital Management, Novo Nordisk's Wegovy, Edge, Inside Edge, CNBC, NBC UNIVERSAL

☆ A famed economist who called the 2008 recession shares 5 signs the US is on the brink of a downturn — all while the stock market shows concerning weakness beneath the surface of record highs
▼ + stars: | 2024-07-13 | by ( William Edwards | ) www.businessinsider.com time to read: +5 min

But don't bet on a soft landing outcome for the US economy as the Fed gets set to cut rates, says famed economist David Rosenberg. AdvertisementRosenberg ResearchRosenberg's downbeat views on the labor market come amid his skepticism about the impressive rallies in major stock-market indexes like the Nasdaq 100 and the S&P 500. Still, as Rosenberg points out, some say the Fed needs to act urgently as the labor market weakens. Waiting too long to lower interest rates to support the economy will only increase the odds of the job market breaking down." Rosenberg has been consistently bearish on the US economy in recent months, while the labor market has continued to prove him wrong.

Persons: —, David Rosenberg, Rosenberg, Merrill Lynch's, Eli Lilly, Russell, Neil Dutta, Dutta Organizations: Service, Fed, Rosenberg Research, Business, Bureau of Labor Statistics ', Survey, Nasdaq, Nvidia, Microsoft, Meta, Macro

☆ What's driving Friday's big market comeback, a day after heavy tech selling
▼ + stars: | 2024-07-12 | by ( Matthew J. Belvedere | ) www.cnbc.com time to read: +5 min

Green day : A lot was working in the stock market on Friday. But it was hard to see through an ugly rotation out of this year's Big Tech winners in favor of more interest rate-sensitive stocks. Many of our hot tech stocks took a breather this week. It's more evidence of why Jim Cramer calls these two names "own, don't trade" stocks. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

Persons: Jim Cramer, Dow, Russell, Eli Lilly, Lilly, Wells Fargo, NII, toolmaker Stanley Black, Decker, Morgan Stanley, That's, Jim Cramer's, Jim Organizations: CNBC, Big Tech, Federal, Nasdaq, PPI, Fed, Meta, Nvidia, Apple, Ford, Abbott Laboratories, Jim Cramer's Charitable, Financial, Nurphoto, Getty Locations: Morphic, Wells, New York City, Mairo

☆ Counterfeit Ozempic Is on the Rise
▼ + stars: | 2024-07-12 | by ( Dani Blum | ) www.nytimes.com time to read: +1 min

Experts have grown increasingly concerned about fake versions of Ozempic and popular weight loss drugs. These copycats can look deceptively real, and may contain dangerous substances or entirely different drugs altogether. In June, the World Health Organization warned that fake batches of Ozempic were found in the United States, the United Kingdom and Brazil. Also in June, Eli Lilly issued a letter expressing concern that counterfeit versions of its own drugs, Mounjaro and Zepbound, were being sold online, through social media and at medical spas. Those who study the counterfeit drug market say these findings are alarming, but not all that surprising.

Persons: Eli Lilly, ”, George Karavetsos Organizations: World Health Organization, Food, Drug, Criminal Investigations Locations: United States, United Kingdom, Brazil

☆ Momentum rules the market this summer, but let the buyer beware
▼ + stars: | 2024-07-11 | by ( Bob Pisani | ) www.cnbc.com time to read: +4 min

For passive investors, it's the best of times: They're seeing new highs on the two major cap-weighted indexes — S & P 500 and the Nasdaq Composite — with low volatility. One example is the Invesco S & P 500 Momentum ETF (SPMO) , which tracks the S & P 500 Momentum Index. That index follows the performance of stocks in the S & P 500 that have a high "momentum score." Momentum ETFs in 2024 S & P 500 up 18.1% Invesco S & P Momentum ETF (SPMO) up 39.9% iShares USA Momentum Factor (MTUM) up 28.5% Both ETFs also have concentrated bets. Why momentum is a risky strategy Let the buyer beware: Everyone looks like a genius holding on to winners in up markets.

Persons: Staples, Invesco, Eli Lilly, it's, It's, rebalanced, Rebalancing Organizations: Nasdaq, Tech, YTD Technology, Energy, Services, Momentum, Nvidia, Apple, Microsoft, Broadcom, Berkshire Hathaway, JPMorgan, Costco Locations: rebalancing

☆ Pfizer moves forward with once-daily version of weight loss pill after setbacks
▼ + stars: | 2024-07-11 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Pfizer on Thursday said it will move forward with a once-daily version of its weight loss pill, danuglipron, after it saw "encouraging" data in an ongoing early-stage trial. Pfizer is one of several drugmakers racing to win a slice of the market for a highly popular class of weight loss and diabetes drugs called GLP-1 agonists. At the time, the pharmaceutical giant said phase one trial data on the once-daily version would "inform a path forward." Pfizer's danuglipron is a GLP-1 that promotes weight loss in the same way as Novo Nordisk' s injection Wegovy and diabetes treatment Ozempic. But he said Pfizer was looking for potential licensing deals or earlier-stage weight loss drugs.

Persons: Albert Bourla, Pfizer's, Eli Lilly, Bourla, Mikael Dolsten, Dolsten Organizations: Pfizer, Novo Nordisk, U.S

☆ Here are Thursday's biggest analyst calls: Nvidia, Apple, Amazon, Spotify, AMD, Uber, McDonald's, Broadcom & more
▼ + stars: | 2024-07-11 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Here are Thursday's biggest calls on Wall Street: Morgan Stanley reiterates Eli Lilly as overweight Morgan Stanley raised its price target on the stock to $1,083 per share from $1,023. "We are initiating RBBN with a Buy rating and $5 price target because the investment thesis has significantly improved." Rosenblatt reiterates Broadcom as buy Rosenblatt raised its price target on the stock to a Street high $2,400. Morgan Stanley downgrades Microchip to equal weight from overweight Morgan Stanley said the semis company has a "lofty" valuation. Morgan Stanley upgrades Telefonica Brasil to overweight from equal weight Morgan Stanley said it's bullish on shares of the LatAm telecom company.

Persons: Morgan Stanley, Eli Lilly, Rosenblatt, Goldman Sachs, Goldman, Mizuho, Truist, Wells, Guggenheim, it's, Jefferies downgrades Darden, Jefferies, Roblox, VIV, OW, Uber, McDonald's Organizations: Broadcom, AVGO, " Bank of America, Apple, Bank of America, JPMorgan, Nvidia, Digital Realty, Mizuho, Services, AMD, Silo AI, KBW, Guggenheim, Costco, Jefferies, Spotify, Telefonica Brasil, Energy, Uber, CART Locations: NYC, Europe, underperform, Olive, China

☆ Stock splits can be rocket fuel for a company's shares. Here's who could be next.
▼ + stars: | 2024-07-11 | by ( Matthew Fox | ) www.businessinsider.com time to read: +3 min

MicroStrategy is the latest company to announce a 10-for-1 stock split as its shares hit $1,340. AdvertisementIt's been a big year for stock splits. According to Bank of America, stock splits can be rocket fuel for prices. Shares of Chipotle have dropped 12% since its shares split 50-for-1 in late June. It represented one of the largest stock splits in the history of the New York Stock Exchange.

Persons: MicroStrategy, —, It's, managements, Steve Sosnick, Eli Lilly, Sosnick Organizations: Service, Nvidia, Walmart, Broadcom, Chipotle, Sony, Lam Research, Texas Pacific, Interactive Brokers, Business, KLA Corp, Netflix, Intuit, Adobe, Bank of America, New York Stock Exchange Locations: Williams, Sonoma, Cintas

Goldman Sachs raised its price target on Tesla, but it still sees a a decline for the electric vehicle maker. Analyst Chris Pierce upgraded his rating to buy from hold and assigned a $160 price target on Carvana, implying shares could jump 27.3%. His $77 price target on Walmart suggests the stock could jump nearly 10.2% over the next 12 months. Analyst Peter Keith assumed coverage of the retailer with a neutral rating and $156 price target, suggesting shares can add 5.7% over the next year. LLY YTD mountain LLY year to date — Pia Singh 5:51 a.m.: Goldman raises Tesla price target, but still sees stock slide Don't expect Tesla's recent momentum to last, according to Goldman Sachs The bank raised its price target on the electric vehicle maker to $248 from $175.

Persons: Tesla, Goldman Sachs, Eli Lilly, Needham, Chris Pierce, Pierce, — Pia Singh, Jefferies, Corey Tarlowe, Tarlowe, Piper Sandler, Peter Keith, Keith, Carter Gould, Gould, Goldman, Mark Delaney, Fred Imbert Organizations: CNBC, Barclays, Jefferies, Walmart, Fox Robotics, EV, Tesla Locations: Tuesday's

☆ Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
▼ + stars: | 2024-07-10 | by ( Julie Coleman | ) www.cnbc.com time to read: +2 min

CNBC's Jim Cramer on Wednesday gave his take on Hims & Hers Health , a digital platform that offers telehealth services, particularly for sexual health, mental health, weight loss and skin care. Cramer suggested it might be worth starting a position in the stock now that it's pulled back some from recent highs. "While it makes sense that the stock roared on this compounded GLP-1 news, I don't love that it's now trading on what's essentially a temporary business," he said. Those great first quarter numbers didn't have any benefit from knock-off GLP-1s, and I bet the business stays strong." Hims & Hers Health did not respond immediately to request for comment.

Persons: CNBC's Jim Cramer, Cramer, it's, I'd, —, Eli Lilly, dalliance Organizations: Wednesday, HIMS, Novo Nordisk

☆ Here are Wednesday's biggest analyst calls: Nvidia, Apple, Netflix, Meta, Tesla, Eli Lilly, Walmart, Microsoft, Oracle & more
▼ + stars: | 2024-07-10 | by ( Michael Bloom | ) www.cnbc.com time to read: +8 min

TD Cowen reiterates Meta as buy TD Cowen raised its price target on Meta to $600 per share from $530. Bank of America downgrades Visa & Mastercard to neutral from buy Bank of America said it sees "limited upside" for the payment stocks. Bank of America downgrades WK Kellogg to underperform from neutral Bank of America said it sees weakening industry trends for WK Kellogg. "We're initiating coverage of Bausch + Lomb (BLCO) with an Outperform rating and $19 price target." Bank of America initiates Composecure as buy Bank of America said it's bullish on shares of the metal payment card manufacturer.

Persons: Bernstein, Iris, it's bullish, Argus, Teva, Piper Sandler downgrades, Piper, Jefferies, Redburn, Goldman Sachs, Tesla, Goldman, Eli Lilly, Morgan Stanley, Needham, BTIG, it's, TD Cowen, Meta, WK Kellogg, Cobra Kai, Truist, Nomura, Raymond James, Bausch Organizations: Iris Energy, Walmart, Fox Robotics, Spotify, Oracle, Barclays, Microsoft, Citi, Quest, Bank of America, MKS, Southwest Citi, Southwest Airlines, Amazon, YouTube, Meta, " Bank of America, Visa, Mastercard, of America, SNAP, Netflix, Apple, Nvidia Locations: Mounjaro, Alaska, Southwest, underperform

☆ Eli Lilly could be next to cross $1 trillion mark, says Jim Cramer
▼ + stars: | 2024-07-10 | by ( Jim Cramer | ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailEli Lilly could be next to cross $1 trillion mark, says Jim Cramer'Mad Money' host Jim Cramer looks at what companies are in the running to join the elite $1 trillion club.

Persons: Eli Lilly, Jim Cramer

Joe Raedle | Getty ImagesAn Express Scripts spokesperson said "the prices of insulin and other medicines are set by their manufacturers, who have raised list prices repeatedly." The FTC's investigation into insulin prices also examines drugmakers, but it is unclear whether they will be named in the upcoming lawsuits, Politico reported, citing sources. Eli Lilly , French drugmaker Sanofi and Danish pharmaceutical company Novo Nordisk control roughly 90% of the U.S. insulin market. They also create lists of medications – or formularies – that are covered by insurance and reimburse pharmacies for prescriptions. Pharmacist Thomas Jensen looks over a prescription drug at the Rock Canyon Pharmacy in Provo, Utah, on May 9, 2019.

Persons: Lina Khan, Tom Williams, Joe Raedle, Eli Lilly, Sanofi, Thomas Jensen, George Frey Organizations: Trade, Financial Services, General Government, CQ, Inc, Getty, Federal Trade Commission, CNBC, UnitedHealth, CVS, Politico, Novo Nordisk, Pharmacy Locations: Miami , Florida, Danish, U.S, Provo , Utah

☆ The best small- and midcap stocks to buy this summer, according to Oppenheimer
▼ + stars: | 2024-07-10 | by ( Sean Conlon | ) www.cnbc.com time to read: +3 min

With the second half of the year underway, Oppenheimer is highlighting what it calls its top small- and midcap seasonal standout investment ideas. On the basis of price charts alone, Oppenheimer tapped midcap growth stocks as its top rotation idea from a technical perspective. Oppenheimer has a $20 price target on Zeta, implying 18% upside from Tuesday's close. In a note last month, RBC Capital Markets also rated Zeta outperform with a price target of $20. In this area, Oppenheimer likes Viking Therapeutics , reiterating the stock as one of its best ideas.

Persons: Oppenheimer, Russell, Brian Schwartz, Zeta, Novo Nordisk's Wegovy, Eli Lilly's Zepbound, Jay Olson, Freshpet Organizations: Oppenheimer, Zeta Global Holdings, Zeta, RBC Capital Markets, Novo Nordisk's, Viking Therapeutics, Therapeutics Locations: Zeta, Novo

☆ Jim Cramer reviews 8 companies that could top $1 trillion in market cap
▼ + stars: | 2024-07-10 | by ( Julie Coleman | ) www.cnbc.com time to read: 1 min

CNBC's Jim Cramer on Wednesday reviewed eight stocks that could join the coveted "trillion-dollar stock club," pinpointing pharmaceutical giant Eli Lilly and electric vehicle maker Tesla as top contenders. Currently, tech giants Apple , Microsoft , Nvidia , Alphabet , Amazon and Meta are the only companies on the market to surpass $1 trillion in market cap. "To me, it's going to be Lilly up next," Cramer said. "But the sheer popularity of Tesla might allow Musk to sneak back into the top rung, turning the Super Six back once again into the Magnificent Seven."

Persons: CNBC's Jim Cramer, Eli Lilly, Tesla, Lilly, Cramer, Musk Organizations: Apple, Microsoft, Nvidia

☆ Federal Trade Commission to sue drug middlemen over prices of medications including insulin, source says
▼ + stars: | 2024-07-10 | by ( Annika Kim Constantino Mary Catherine Wellons | Annika Kim Constantino | Mary Catherine Wellons | ) www.cnbc.com time to read: +3 min

Joe Raedle | Getty ImagesAn Express Scripts spokesperson said the "prices of insulin and other medicines are set by their manufacturers, who have raised list prices repeatedly." They also create lists of medications — or formularies — that are covered by insurance and reimburse pharmacies for prescriptions. The investigation into insulin prices also examines drugmakers, but it is unclear whether they will be named in the upcoming lawsuits, Politico reported, citing people familiar with the matter. Eli Lilly , French drugmaker Sanofi and Danish pharmaceutical company Novo Nordisk control roughly 90% of the U.S. insulin market. Pharmacist Thomas Jensen looks over a prescription drug at the Rock Canyon Pharmacy in Provo, Utah, on May 9, 2019.

Persons: Lina Khan, Tom Williams, Joe Raedle, PBMs, Eli Lilly, Sanofi, Thomas Jensen, George Frey Organizations: Trade, Financial Services, General Government, CQ, Inc, Getty, Federal Trade Commission, CNBC, UnitedHealth, CVS, FTC, Politico, Novo Nordisk, Pharmacy Locations: Miami, U.S, Danish, Provo , Utah

☆ Stocks making the biggest moves midday: Nvidia, Corning, Helen of Troy, UiPath and more
▼ + stars: | 2024-07-09 | by ( Sean Conlon | ) www.cnbc.com time to read: +3 min

Helen of Troy — The housewares stock plummeted nearly 28%, hitting a new 52-week low during the session. The company posted an earnings miss for its first quarter of fiscal 2025 before the bell, earning 99 cents per share, excluding items. Lucid — The electric vehicle company's stock added nearly 1% after rallying about 8% in the previous session. Lucid jumped after the firm said it delivered 2,394 vehicles in the second quarter, marking a 70% year-over-year increase. Tesla — Shares of the electric vehicle company popped more than 4%.

Persons: Blackwell, Helen of Troy —, FactSet, UiPath, Lucid, Eli Lilly's Mounjaro, Eli Lilly, Morgan Stanley, Corning, Yun Li, Pia Singh, Sarah Min, Darla Mercado Organizations: Nvidia, UBS, BP — U.S, Novo Nordisk, Novo Nordisk's Ozempic, Sony, Paramount, National Amusements, Skydance Media, Apollo, CNBC Locations: Novo

☆ Here's why KeyBanc analysts see more than 40% upside for Nvidia stock
▼ + stars: | 2024-07-09 | by ( Morgan Chittum | ) www.cnbc.com time to read: +2 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. KeyBanc raised its price target on the Club chipmaker's stock to $180 per share from $130. New research indicated that tirzepatide, the active ingredient in Lilly's Mounjaro for diabetes and Zepbound for weight loss leads to more weight loss than Novo Nordisk's semaglutide. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Goldman Sachs, Piper Sandler, —, KeyBanc, Eli Lilly, Lilly, Jim Cramer's, Jim Organizations: CNBC, Nasdaq, Apple, Big Tech, Nvidia, Club, Blackwell, Novo Nordisk's semaglutide

☆ We're hiking our price targets on Meta, Eli Lilly, and 3 other stocks on recent runs higher
▼ + stars: | 2024-07-09 | by ( Jeff Marks | ) www.cnbc.com time to read: +5 min

AMZN YTD mountain Amazon YTD We begin with Amazon 's move, which has been fueled by strength in its three core businesses. GOOGL YTD mountain Alphabet YTD Alphabet has been gaining steam in recent months on similar cloud tailwinds but also improving sentiment around its AI capabilities. META YTD mountain Meta Platforms YTD Meta Platforms ' stock has fully recovered all of its first-quarter earnings losses. LLY YTD mountain Eli Lilly YTD We are also increasing our Eli Lilly price target – taking it to $1,000 per share from $850. PANW YTD mountain Palo Alto Networks YTD One more stock we're raising our price target for is Palo Alto Networks .

Persons: Eli Lilly, Eli Lilly YTD, There's, donanemab, We're, Jim Cramer's, Jim Cramer, Jim, Beata Zawrzel Organizations: Palo Alto Networks, Amazon, Jefferies, Facebook, Alto Networks, CNBC, Google, Nurphoto, Getty Locations: CIOs, United States, Indiana, Palo

☆ Stocks making the biggest moves premarket: Paramount, SolarEdge, Morphic Holding and more
▼ + stars: | 2024-07-08 | by ( Hakyung Kim | ) www.cnbc.com time to read: +2 min

Morphic Holding — Shares surged more than 75% on news that Eli Lilly will acquire the biopharma company in a $3.2 billion deal . The deal will give Eli Lilly access to Morphic's portfolio of treatments in development, such as those for ulcerative colitis and Crohn's disease. Eli Lilly shares inched up 0.2% on the news. SolarEdge — The energy company rose 5% after Bank of America upgraded shares to neutral from underperform, citing an attractive entry point for investors. Gilead — Shares of the biotech stock rose more than 2% after an upgrade to outperform from market perform at Raymond James.

Persons: Eli Lilly, SolarEdge, Guggenheim, ServiceNow, John DiFucci, Baird, Gilead —, Raymond James, Gilead, Sarah Min, Jesse Pound, Michelle Fox, Yun Li Organizations: Paramount, Skydance Media, Bank of America, PNC, UBS, KeyCorp, Columbia, —

☆ Stocks making the biggest moves midday: Paramount Global, Morphic Holding, Ideaya Biosciences and more
▼ + stars: | 2024-07-08 | by ( Sean Conlon | ) www.cnbc.com time to read: +3 min

Skydance and its financial backers will invest more than $8 billion into Paramount and to acquire National Amusements, Paramount's controlling shareholder. Morphic Holding – Shares rallied 75% on news that Eli Lilly will acquire the biopharmaceutical company in a $3.2 billion deal . The deal will give Eli Lilly access to Morphic's portfolio of treatments in development, such as those for ulcerative colitis and Crohn's disease. Shares of Eli Lilly advanced 1.3% on the news. Boeing – Shares fell slightly after the airplane maker agreed to plead guilty to criminal fraud related to the fatal 737 Max crashes, sparing Boeing from a trial.

Persons: Eli Lilly, BofA, Corning, Guggenheim, Max, Grayson, Raymond James, Samantha Subin, Pia Singh, Hakyung Kim, Sarah Min, Michelle Fox Organizations: Paramount Global, Skydance Media, Skydance, Paramount, National, Morphic, Ideaya Biosciences, Bank of America, Boeing –, Boeing, ., CNBC, Devon Energy, Gilead Sciences Locations: Columbia, Stifel, Williston, Gilead

☆ Mounjaro leads to significantly more weight loss than Ozempic, study suggests
▼ + stars: | 2024-07-08 | by ( Deidre Mcphillips | ) edition.cnn.com time to read: +4 min

CNN —People taking tirzepatide injections lost more weight and were more likely to reach specific weight loss targets than those taking semaglutide, according to a new study. But 82% of people taking tirzepatide reached this important clinical benchmark, compared with about 67% of those taking semaglutide. Average weight loss was also consistently higher among those taking tirzepatide over time. And by one year, average weight loss was nearly double for those taking tirzepatide — more than 11%, compared with about 6% for those taking semaglutide. According to the new study, individuals with type 2 diabetes had less significant weight loss than those without a diagnosis — but average weight loss was still greater among those taking tirzepatide.

Persons: tirzepatide, Eli Lilly, ”, Dr, Sanjay Gupta, CNN’s Brenda Goodman Organizations: CNN, US Food and Drug Administration, Novo Nordisk, semaglutide, FDA, CNN Health Locations: Truveta

Search resuls for: "lilly"

25 mentions found